Company profile: Frame Therapeutics
1.1 - Company Overview
Company description
- Provider of DNA-based cancer vaccines tailored to the unique characteristics of each patient's tumor, aiming to transform cancer treatment by directing the immune system toward Frame neoantigens.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Frame Therapeutics
Hepion Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical drug development, featuring rencofilstat, a cyclophilin inhibitor aimed at reducing liver fibrosis and hepatocellular carcinoma tumor burden, currently in Phase 2 for NASH, and a proprietary AI/ML platform to understand disease processes and identify patients who respond to rencofilstat, potentially shortening development timelines and enhancing clinical trial outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hepion Pharmaceuticals company profile →
Arch Oncology
HQ: United States
Website
- Description: Provider of venture-stage biopharmaceutical solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arch Oncology company profile →
Onyvax
HQ: United Kingdom
Website
- Description: Provider of cancer therapies that harness the immune system’s selective power to seek out and destroy tumor cells, specifically targeting cancer cells to improve effectiveness while minimizing side effects compared to conventional treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Onyvax company profile →
Alzamend Neuro
HQ: United States
Website
- Description: Provider of biotech therapies for Alzheimer's disease that develops and commercializes drugs, treatments, and cures. Includes AL001, an ionic cocrystal delivering lithium via lithium/proline/salicylate for Alzheimer's, bipolar disorder, major depressive disorder, and PTSD; and ALZN002, a cell-based therapeutic vaccine using a mutant-peptide sensitized cell to restore the patient's immune system's ability to combat Alzheimer's.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alzamend Neuro company profile →
iTeos Therapeutics
HQ: United States
Website
- Description: Provider of immuno-oncology drug discovery and development focused on tumor immunology and the metabolism of the tumor microenvironment, delivering small molecule immunomodulators and antibody therapies for cancer. Portfolio includes EOS-448 (anti-TIGIT IgG1), Inupadenant (A2AR inhibitor), and EOS-984 (preclinical). Conducts clinical trials and advances monotherapy and combination therapy approaches across cancer indications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iTeos Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Frame Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Frame Therapeutics
2.2 - Growth funds investing in similar companies to Frame Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Frame Therapeutics
4.2 - Public trading comparable groups for Frame Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →